Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database.
作者： Lin Li , Andrew Roddam , Matthew Gitlin , Andrew Taylor , Susan Shepherd
DOI: 10.1097/GME.0B013E318221BACD
关键词:
摘要: AbstractObjectiveThe aims of this study were to estimate persistence with osteoporosis therapies and assess by different users (stable switching), type drug, calendar year initiation among postmenopausal women.MethodsThis was conducted using the data f
sci-hub.se 参考文章(19)
Luis A. García Rodríguez, Susanne Pérez Gutthann, Use of the UK General Practice Research Database for pharmacoepidemiology British Journal of Clinical Pharmacology. ,vol. 45, pp. 419- 425 ,(1998) , 10.1046/J.1365-2125.1998.00701.X
Tjeerd Van Staa, Arlene M Gallagher, Stephan Rietbrock, Melvin Olson, Tjeerd P van Staa, Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates Journal of Bone and Mineral Research. ,vol. 23, pp. 1569- 1575 ,(2008) , 10.1359/JBMR.080510
J. C. Lo, A. R. Pressman, M. A. Omar, B. Ettinger, Persistence with weekly alendronate therapy among postmenopausal women Osteoporosis International. ,vol. 17, pp. 922- 928 ,(2006) , 10.1007/S00198-006-0085-2
Joyce A. Cramer, Niall O. Lynch, Anne-Francoise Gaudin, Mel Walker, Warren Cowell, The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: A comparison of studies in the United States, the United Kingdom, and France Clinical Therapeutics. ,vol. 28, pp. 1686- 1694 ,(2006) , 10.1016/J.CLINTHERA.2006.10.013
Hershel Jick, Barbara Z. Terris, Laura E. Derby, Susan S. Jick, Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom Pharmacoepidemiology & Drug Safety. ,vol. 1, pp. 347- 349 ,(1992) , 10.1002/PDS.2630010607
Eamonn Brankin, Mel Walker, Niall Lynch, Terence Aspray, Yvonne Lis, Warren Cowell, The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Current Medical Research and Opinion. ,vol. 22, pp. 1249- 1256 ,(2006) , 10.1185/030079906X112688
I. Imaz, P. Zegarra, J. González-Enríquez, B. Rubio, R. Alcazar, J. M. Amate, Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis Osteoporosis International. ,vol. 21, pp. 1943- 1951 ,(2010) , 10.1007/S00198-009-1134-4
François-Emery Cotté, Florence Mercier, Gérard De Pouvourville, Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case—control analysis Clinical Therapeutics. ,vol. 30, pp. 2410- 2422 ,(2008) , 10.1016/J.CLINTHERA.2008.12.019
J. A. Cramer, D. T. Gold, S. L. Silverman, E. M. Lewiecki, A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporosis International. ,vol. 18, pp. 1023- 1031 ,(2007) , 10.1007/S00198-006-0322-8
Samuel D. Vasikaran, Utility of Biochemical Markers of Bone Turnover and Bone Mineral Density in Management of Osteoporosis Critical Reviews in Clinical Laboratory Sciences. ,vol. 45, pp. 221- 258 ,(2008) , 10.1080/10408360801949442